The latest price target for Lilium (NASDAQ:LILM) was reported by Cantor Fitzgerald on August 19, 2024. The analyst firm set a price target for $2.00 expecting LILM to rise to within 12 months (a possible 159.37% upside). 5 analyst firms have reported ratings in the last year.

The latest analyst rating for Lilium (NASDAQ:LILM) was provided by Cantor Fitzgerald, and Lilium reiterated their overweight rating.

The last upgrade for Lilium NV happened on July 17, 2023 when Canaccord Genuity raised their price target to $3. Canaccord Genuity previously had a hold for Lilium NV.

The last downgrade for Lilium NV happened on December 7, 2022 when Barclays changed their price target from $2 to $1 for Lilium NV.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lilium, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lilium was filed on August 19, 2024 so you should expect the next rating to be made available sometime around August 19, 2025.

While ratings are subjective and will change, the latest Lilium (LILM) rating was a reiterated with a price target of $2.00 to $2.00. The current price Lilium (LILM) is trading at is $0.77, which is out of the analyst’s predicted range.